GoldBamboo.com - Knowledge is strong medicine
  

Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects with Crohn's Disease - Article


  Not Signed In - Sign In / Register







[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]

Crohn's Disease

Crohn's disease; Crohn//'s disease; Inflamatory Bowel Disease; Inflammatory Bowel Disease, Crohn's




Clinical Trial: Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects with Crohn's Disease

This study is currently recruiting patients.

Sponsored by: Abbott Laboratories
Information provided by: Abbott Laboratories

Purpose

The goal of this study is to test whether adalimumab can induce clinical remission in subjects with active Crohn's disease who have been initially treated with infliximab and either lost response or discontinued its use as a result of intolerance to the drug.

Condition Treatment or Intervention Phase
Crohn's Disease
 Drug: Adalimumab
Phase III

MedlinePlus related topics:  Crohn's Disease

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control

Official Title: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects with Moderate to Severe Crohn's Disease who Have Lost Response or are Intolerant to Infliximab

Further Study Details: 

Expected Total Enrollment:  300

Study start: October 2004

Eligibility

Ages Eligible for Study:  18 Years   -   75 Years,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

  • Males and females between the ages of 18 and 75 who are diagnosed with mild to moderate Crohn's disease (defined by a CDAI [Crohn's Disease Activity Index] score of 220 and 450)
  • Normal lab parameters
  • Are willing to give informed consent
  • Have previously used and either were intolerant to or lost response to infliximab

Exclusion Criteria:

  • History of certain types of cancer
  • Diagnosis of ulcerative colitis
  • Pregnant female or breast feeding subjects
  • Known obstructive strictures
  • Surgical bowel resection in the past 6 months
  • History of listeria, human immunodeficiency virus (HIV), central nervous system demyelinating disease or untreated TB (tuberculosis)
  • History of poorly controlled medical conditions
  • Specific doses and durations of Crohn's medications
  • Subjects that have previously used infliximab and have never clinically responded unless primary non-response was due to a treatment limiting reaction to infliximab

Location and Contact Information

Marie Nickle, BA      973-394-5513    marie.nickle@abbott.com

Alabama
      Clinical Research Associates, Huntsville,  Alabama,  35801,  United States; Recruiting
Peg Rochine  256-536-6600    prochine@clinicalresearchassociates.biz 
Allen Goetsch, MD,  Principal Investigator

California
      Medical Associates Research Group, San Diego,  California,  92123,  United States; Recruiting
Dianne Touhy  858-277-5678    dianne.tuohy@marginc.com 
Michael Bennett, MD,  Principal Investigator

      Sharp Rees-Stealy Medical Group, San Diego,  California,  92123,  United States; Recruiting
Catherine Goodwater  858-541-6594    Catherine.Goodwater@sharp.com 
Bruce R Johnson, MD,  Principal Investigator

      Capitol Gastroenterology Consultants Medical Group, Inc., Roseville,  California,  95661,  United States; Recruiting
Christy Bellamy-Pifer, B.S., CRC  609-407-1220    Cpifer@capitolgi.com 
Theodor Feinstat, MD,  Principal Investigator

Colorado
      SMC-Trauma Research, Englewood,  Colorado,  80113,  United States; Recruiting
Eli Landry  303-788-4051    elilandry@aol.com 
Lawrence Kim, MD,  Principal Investigator

Florida
      Borland-Groover Clinic, Jacksonville,  Florida,  32256,  United States; Recruiting
Linda Burton  904-680-0871    lburton@BGClinic.com 
Lawrence Goldberg, MD,  Principal Investigator

      Shafran Gastroenterology Center, Winter Park,  Florida,  32789,  United States; Recruiting
Johnathan Decker  407-629-8121    nursej1@msn.com 
Ira Shafran, MD,  Principal Investigator

      V.A. Medical Center, Gainesville,  Florida,  32608,  United States; Recruiting
Theresa Huber  352-376-1611  Ext. x6942    Theresa.Huber2@med.va.gov 
John Valentine, MD,  Principal Investigator

      Clinical Research of West Florida, Inc, Clearwater,  Florida,  33765,  United States; Recruiting
Pamela Darley  727-466-0078  Ext. x226    pdarley@crwfinc.com 
Michael Weiss, MD,  Principal Investigator

Georgia
      Pinnacle Trials, Inc., Atlanta,  Georgia,  30329,  United States; Terminated

      Atlanta Gastroenterology Assoc., Atlanta,  Georgia,  30342,  United States; Not yet recruiting
Meredith Mourm  404-257-9000    m4desk@aol.com 
Douglas C. Wolf, MD,  Principal Investigator

Illinois
      Ntouch Research, Peoria,  Illinois,  60602,  United States; Recruiting
Sharon Thompson  309-672-1910  Ext. x 122    sthompson@ntouchresearch.com 
Ben Dolin, MD,  Principal Investigator

      The University of Chicago, Chicago,  Illinois,  60673,  United States; Recruiting
Heather Brenner  773-702-1466    Hbrenner@medicine.bsd.uchicago.edu 
Stephen B Hanauer, MD,  Principal Investigator

Indiana
      Outpatient Clinical Research Facility University of Indianapolis, Indianapolis,  Indiana,  462025250,  United States; Not yet recruiting
Marta Sears  317-274-3974    msears@iupui.edu 
Debra J Helper, MD,  Principal Investigator

Kentucky
      University of Kentucky Medical Center Division of Digestive Diseases, Lexington,  Kentucky,  40536,  United States; Recruiting
Jeri Reynolds  859-323-6423    jeri.reynolds@uky.edu 
Willem de Villiers, MD,  Principal Investigator

Louisiana
      Drug Research Services, Inc., Metairie,  Louisiana,  70001,  United States; Recruiting
Catina Gordon-Oates  504-456-1433    catina@drsinc.net 
David R Silvers, MD,  Principal Investigator

Maryland
      Chevy Chase Clinical Research, Chevy Chase,  Maryland,  20815,  United States; Recruiting
Susanna Milton  301-652-5520    robidoc@aol.com 
Robert Hardi, MD,  Principal Investigator

      Charm City Research, Towson,  Maryland,  21204,  United States; Recruiting
Janet Heidrick  410-825-4200    jheidrick@charmcity.com 
James Novick, MD,  Principal Investigator

Minnesota
      Mayo Clinic Research, Rochester,  Minnesota,  559050002,  United States; Recruiting
Resa Jeche  507-284-2511    jeche.resa@mayo.edu 
William Sandborn, MD,  Principal Investigator

      Minnesota Gastroenterology P.A., Plymouth,  Minnesota,  55446,  United States; Not yet recruiting
Karah Neisen  612-870-5594    KNeisen@mngastro.com 
Robert McCabe, MD,  Principal Investigator

Mississippi
      Gastrointestinal Associated, P.A., Jackson,  Mississippi,  39202,  United States; Recruiting
Donna Darwin  601-683-0395    ddarwin@sumres.com 
Billy Long, MD,  Principal Investigator

Missouri
      St. Louis Center for Clinical Research, St. Louis,  Missouri,  63128,  United States; Recruiting
Melissa Donlon  314-543-5225    investigators@slccr.com 
James Dimitroff, MD,  Principal Investigator

      Glen Gordon, MD, Mexico,  Missouri,  65265,  United States; Recruiting
Brenda Gordon  573-581-7196    brenda@gutdoc.net 
Glenn Gordon, MD,  Principal Investigator

New Jersey
      Atlantic Gastroenterology Associates, LLC, Egg Harbor Township,  New Jersey,  08234,  United States; Recruiting
Theresa Stevens  609-407-1220 
Barry Kaufman, MD,  Principal Investigator

New York
      NY Center for Clinical Research, Lake Success,  New York,  11042,  United States; Recruiting
Melissa Erdvig  516-326-2700    merdvig@aol.com 
David Eskreis, MD,  Principal Investigator

      Long Island Clinical Research Assoc. LLP, Great Neck,  New York,  11021,  United States; Not yet recruiting
Andy Mulchinski  516-466-1051    Amulchinski@liclinical.com 
Seymour Katz, MD,  Principal Investigator

North Carolina
      Wake Research Associates, Raleigh,  North Carolina,  27612,  United States; Recruiting
Marsha Peery  919-781-2514    mpeery@wakeresearch.com 
Charles Barish, MD,  Principal Investigator

      Asheville Gastroenterology Associates, Ashville,  North Carolina,  28801,  United States; Recruiting
Geoffrey Kitchingman  828-254-0881  Ext. x 388    Geoffrey.Kitchingman@ashevillegastro.com 
William R Harlan, MD,  Principal Investigator

Ohio
      Gastroenterology Associates of Cleveland, Mayfield Heights,  Ohio,  44124,  United States; Recruiting
Sue Davies  440-442-6173    research@gastro-associates.com 
Dianne Himmelman  440-442-6173    research@gastro-associates.com 
Michael Frankel, MD,  Principal Investigator

      Gastrointestinal and Liver Disease Consultants, Dayton,  Ohio,  45440,  United States; Recruiting
Mary Harvey  937-307-9931    targetrsch@aol.com 
Donald Lutter, MD,  Principal Investigator

      Consultants for Clinical Research, Cincinnati,  Ohio,  45219,  United States; Not yet recruiting
Linda Magaw  513-872-4549    gcombs@ccrstudy.com 
Alan V Safdi, MD,  Principal Investigator

      Cleveland Clinic Foundation, Cleveland,  Ohio,  44195,  United States; Not yet recruiting
Amy Knesebeck, RN  216-444-6524    lashneb@ccf.org 
Bret Lashner, MD,  Principal Investigator

Oregon
      The Oregon Clinic, PC Gastroenterology Division, Portland,  Oregon,  97220,  United States; Recruiting
Tim Miller, BS, CRC  503-963-2756    tmiller@orclinic.com 
Phillip K Kiyasu, Md,  Principal Investigator

Pennsylvania
      Regional Gastroenterologist Associates of Lancaster, Lancaster,  Pennsylvania,  17604,  United States; Terminated

      University of Pittsburgh Medical Center, Pittsburgh,  Pennsylvania,  15261,  United States; Recruiting
Kimberly Jones  412-648-9083    jonesk@msx.dept-med.pitt.edu 
Miguel Regueiro, MD,  Principal Investigator

South Carolina
      Columbia Gastro Associates, Columbia,  South Carolina,  29204,  United States; Recruiting
Sandy Boone, MD  803-419-2120    sfboone@bellsouth.net 
John Popp, MD,  Principal Investigator

Tennessee
      Gastrointestinal Associates, Knoxville,  Tennessee,  37909,  United States; Recruiting
Jan Miller  865-583-1286 
John Haydek, MD,  Principal Investigator

      Vanderbilt University Medical Center, Nashville,  Tennessee,  37232,  United States; Not yet recruiting
Karen Bargatze  615-322-8398    karen.bargatze@vanderbilt.edu 
David Schwartz, MD,  Principal Investigator

      Gastroenterology Center of the Mid South, Memphis,  Tennessee,  38120,  United States; Recruiting
Jim Marchand  901-820-0090    jamesm@gicentermidsouth.com 
Zaid Younes, MD,  Principal Investigator

Texas
      Austin Gastroenterology, Austin,  Texas,  78745,  United States; Recruiting
Linda Salas  512-532-8028    lindas@austingastro.com 
William Stassen, MD,  Principal Investigator

Utah
      Wasatch Clinical Research, Salt Lake City,  Utah,  84107,  United States; Not yet recruiting
Karen George  801-288-0607    kgeorge@wasatchcrc.com 
P J. Pederson, M.D.,  Principal Investigator

Virginia
      Digestive and Liver Disease, Norfolk,  Virginia,  23205,  United States; Recruiting
Becky Mosconi  757-466-0165    beckym@dlds.org 

      Internal Medicine Associates, Danville,  Virginia,  25451,  United States; Recruiting
Trisha Jones  434-792-2339  Ext. x 118    imadanville@aol.com 
Jack Bryan Spainhour, MD,  Principal Investigator

Washington
      Spokane Digestive Disease Center, Spokane,  Washington,  99204,  United States; Recruiting
Jeannell Love, CCRC  509-232-4265    jlove@sddcdocs.com 
Karl Houglum, MD,  Principal Investigator

Wisconsin
      Discovery Research International, LLC, Milwaukee,  Wisconsin,  53207,  United States; Recruiting
Kathy Otto  414-385-8680    dri@dozerresearch.com 
David Dozer, MD,  Principal Investigator

More Information

Study ID Numbers:  M04-691
Record last reviewed:  March 2005
Last Updated:  March 29, 2005
Record first received:  March 11, 2005
ClinicalTrials.gov Identifier:  NCT00105300
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08


Source: ClinicalTrials.gov
Cache Date: April 9, 2005


Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Crohn's Disease.

December 4, 2008



Page Updated: May 11, 2006
============== Advertisement ==============
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC - All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.